PSYCSpotlight

3.7K posts

PSYCSpotlight banner
PSYCSpotlight

PSYCSpotlight

@PSYC_Spot

The leading voice for news on the psychedelics industry covering breakthrough discoveries, investor news & pop culture. OTC: $PSYC

Mars Katılım Mart 2022
821 Takip Edilen3K Takipçiler
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
The 2nd International Society for Research on Psychedelics (ISRP) meeting is in New Orleans Feb 16-18, 2024. Support and interest has been very strong, with an expected 140 registrants, 50 oral presentations and 30 posters. Hope to see you there! isrpsych.org
PSYCSpotlight tweet media
English
2
1
4
1.1K
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
As investors pile into psychedelics, idealism gives way to pharma economics “All the air is getting sucked out of the room by these for-profit companies who say, ‘Wow, this stuff is awesome, if I could patent it I’d make a fortune.’” cp24.com/world/as-inves…
English
2
6
15
1.5K
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Al Jazeera explores the boom of magic mushroom retreats in its Mindset docuseries. The crew travels to Jamaica to meet the doctors, patients and retreat workers driving the country’s "shroom boom". youtube.com/watch?v=9_DZwK…
YouTube video
YouTube
English
1
4
5
704
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Psychedelics might be legal sooner than you think! With the FDA reviewing psychedelic treatments, approval would lead to DEA reclassification and open a world of new mental health treatments! on.natgeo.com/3uefvwy
English
3
10
35
1.4K
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
People use drugs like Xanax to halt a bad psychedelic trip — but "trip killers" also come with risks bit.ly/3OoxVSd
English
3
0
1
341
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
79% of Canadians Support Psilocybin To Treat Existential Dread for End of Life Patients Researchers also asked survey participants about their opinions on whether psilocybin should be covered by the country’s public health system. bit.ly/3SBJckD
English
5
6
23
1.2K
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Psychedelic Censorship: Let Mushroom Educators Have Their Say For legal small businesses, advocates and educators in the psychedelic or cannabis space, losing your social media account is common. bit.ly/4b6kSOZ
English
3
0
0
344
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
The EU has awarded €6.5M to support a multi-site randomized controlled trial of psilocybin to ease psychological and existential distress in a variety of progressive illnesses like multiple sclerosis (MS) and chronic obstructive pulmonary disorder (COPD). bit.ly/3SvYM0R
English
1
3
8
799
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
What Happens in the Human Brain After Taking DMT? Combining EEG and fMRI, scientists explore the effects of DMT on the human brain. bit.ly/48Fv935
English
2
0
6
343
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
A slowly increasing number of employers—mostly those who’ve experienced the benefits themselves—are giving their employees access to psychedelic-assisted psychotherapy as part of their health plan. bit.ly/47KgPF8
English
2
3
4
435
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
New study: Psilocybin's impact on rat brain connectivity offers hope for alcohol addiction treatment. Severity of addiction may shape response. bit.ly/3Hsgqw5
English
4
9
21
2.4K
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Psychedelics gave terminal patients relief from their intense anxiety. End-of-life cancer patients in a therapy group in Canada used psilocybin to reduce their fears. It helped some find peace. wapo.st/48UE8ge
English
6
0
4
437
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
New research on DMT! 🌌 Inhaling DMT is safe and effective. 27 healthy volunteers tested doses from 5mg to 60mg. Results show no safety concerns, and stronger effects lead to more positive experiences. bit.ly/47u71Pf
English
0
5
5
669
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Red and blue both trip on the same hue? In a national survey, 795 nationally representative US Americans from across the political spectrum showed bipartisan support for supervised psilocybin use. bit.ly/3U3UXRE
PSYCSpotlight tweet media
English
3
1
1
490
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
A Phase III trial, found that a 4-week course of subcutaneous ketamine was more effective than midazolam in treating treatment-resistant depression, with a remission rate of 19.6% compared to 2.0% in the flexible-dose cohort. bit.ly/47v7O2k
English
1
0
2
320
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
Encountering complications can definitely make one’s dive into their subconscious more challenging and quite unpleasant. One of these adverse reactions is tetany... bit.ly/3RV2mjE
English
0
0
2
273
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
In Zoladz’s preclinical research, he, along with others, have been working with rats to try and reduce fear memories. They’re doing that by giving them psilocybin. bit.ly/4aPHUJw
English
1
0
4
514
PSYCSpotlight
PSYCSpotlight@PSYC_Spot·
The Awakening the Soul 2022 documentary is a MUST WATCH! The film takes the audience through a visionary journey exploring the wisdom teachings, guidance, integration, psychology and integrity required to steward such a powerful experience. bit.ly/3RQ2yk8
English
0
0
1
276